These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 12813456)

  • 1. Interaction of the HPV E7 proteins with the pCAF acetyltransferase.
    Avvakumov N; Torchia J; Mymryk JS
    Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
    Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
    Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
    Hermonat PL; Santin AD; Zhan D
    J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of p53 transcriptional activity by the HPV E7 proteins.
    Massimi P; Banks L
    Virology; 1997 Jan; 227(1):255-9. PubMed ID: 9007083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
    Münger K; Scheffner M; Huibregtse JM; Howley PM
    Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro.
    Nakagawa S; Watanabe S; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    Virology; 1995 Oct; 212(2):535-42. PubMed ID: 7571423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of transformation by the human papillomaviruses.
    Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
    Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
    Velazquez Torres A; Gariglio Vidal P
    Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity.
    Wang YW; Chang HS; Lin CH; Yu WC
    Int J Biochem Cell Biol; 2007; 39(2):402-12. PubMed ID: 17070091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
    Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
    Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity.
    Prathapam T; Kühne C; Banks L
    Oncogene; 2001 Nov; 20(52):7677-85. PubMed ID: 11753645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
    Brokaw JL; Yee CL; Münger K
    Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.
    Pim D; Storey A; Thomas M; Massimi P; Banks L
    Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.
    Gammoh N; Grm HS; Massimi P; Banks L
    J Virol; 2006 Feb; 80(4):1787-97. PubMed ID: 16439535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein.
    Zwerschke W; Joswig S; Jansen-Dürr P
    Oncogene; 1996 Jan; 12(1):213-20. PubMed ID: 8552395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors.
    Toussaint-Smith E; Donner DB; Roman A
    Oncogene; 2004 Apr; 23(17):2988-95. PubMed ID: 14968115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene.
    Vousden KH; Doniger J; DiPaolo JA; Lowy DR
    Oncogene Res; 1988 Sep; 3(2):167-75. PubMed ID: 2852339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
    Uversky VN; Roman A; Oldfield CJ; Dunker AK
    J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes.
    Zhang B; Laribee RN; Klemsz MJ; Roman A
    Virology; 2004 Nov; 329(1):189-98. PubMed ID: 15476886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.